Cargando…

LBSUN292 Learning Lesson From A Case of Fulminant Type 1 Diabetes Mellitus Shortly After Pembrolizumab Treatment

BACKGROUND: Immune checkpoint inhibitors (ICIs) in cancer treatment are considered one of the major breakthroughs in the past decade. Pembrolizumab (PBL) is one of the immune checkpoint inhibitors that targets the programmed cell death protein-1 (PD-1) receptor in order to block its interaction with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phan, Van, Nguyen, Quan, Phan, Vien, Erenler, Feyza, Pittas, Anastassios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Diabetes & Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629389/ http://dx.doi.org/10.1210/jendso/bvac150.600

Ejemplares similares

SAT142 Utilization Of Continuous Glucose Monitoring In Diagnosis And Management Of Insulinoma
por: Phan, Van, et al.
Publicado: (2023)

THU374 Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab
por: Iqbal, Iqra, et al.
Publicado: (2023)

SAT148 A Rare Case Of Proinsulinoma In A Patient With Type 2 Diabetes Mellitus
por: Tirthani, Ekta, et al.
Publicado: (2023)

LBSUN332 A Novel Drug To Modulate Auto-inflammation And Promote Glucose Control In Type 1 Diabetes Mellitus
por: Wagner, David, et al.
Publicado: (2022)

LBSUN152 The Warburg Effect And Complex Thermomics Inform Phenotypic Expression
por: Fredericks, Robert S
Publicado: (2022)

LBSUN151 The Impact Of The COVID-19 Pandemic On Diabetes & Weight Management
por: Hashmi, Hiba Z, et al.
Publicado: (2022)

LBSUN205 Clinical Practice Guidelines With Education Make A Difference
por: Mohieldin, Mohamed Elfatih
Publicado: (2022)

LBSUN213 An Investigation Into The Effects Of Dapagliflozin On Ketogenesis In Type 1 Diabetes
por: Ghanim, Husam, et al.
Publicado: (2022)

LBSUN291 Fournier's Gangrene In A Diabetic Male Taking Dapagliflozin
por: Patel, Janki M, et al.
Publicado: (2022)

ODP211 Impact of Race and Chronic Kidney Disease on the Correlation between HbA1c and Continuous Glucose Monitoring (CGM) Glycemic Measures
por: Kaplan, Leah, et al.
Publicado: (2022)

LBSUN331 Rescuing Alpha Cell Responses To Hypoglycemia In Type 1 Diabetes
por: Panzer, Julia, et al.
Publicado: (2022)

LBSUN214 Accuracy Of A Continuous Glucose Monitor In The Intensive Care Unit
por: Bann, Sewon, et al.
Publicado: (2022)

LBSUN321 Development And Pilot Testing Of Barriers To Diabetic Foot Care With A Qualitative Assessment
por: Blanco, Gerardo, et al.
Publicado: (2022)

LBSUN208 Patient Education And Addressal Of Social Determinants Of Health: Key To Improvement In Diabetes Care
por: Manas, F N U, et al.
Publicado: (2022)

LBSUN209 A Novel Algorithm For The Management Of Inpatient Covid-19 Steroid-induced Hyperglycemia
por: Karol, Alexander B, et al.
Publicado: (2022)

LBSUN309 The Effect Of Prebiotics In Newly Diagnosed Youth With Type 1 Diabetes (T1D)
por: Ismail, Heba, et al.
Publicado: (2022)

LBSUN307 A Randomized Controlled Pilot Study Of The Food Order Behavioral Intervention In Prediabetes
por: Shukla, Alpana P, et al.
Publicado: (2022)

LBSUN178 Teniposide Improves Adeno-associated Virus-mediated Insulin Gene Therapy In Diabetic Mice.
por: Akcan, Tugce, et al.
Publicado: (2022)

LBSUN211 The Importance Of Early Opportunities To Identify And Treat Prediabetes Or Even Change The Diagnostic Threshold For Diabetes
por: Schwartz, Stanley S, et al.
Publicado: (2022)

LBSUN161 Relationship Of Shape Of Glucose OGTT Curves With Measures Of Cardiometabolic Health In African American Adolescents
por: Thaker, Vidhu, et al.
Publicado: (2022)

LBSUN288 Improved Glycemic Control Following Oophorectomy In A Post-menopausal Woman With Ovarian Hyperthecosis
por: Learned, Brooke Noelle, et al.
Publicado: (2022)

LBSUN149 Effectiveness Of Digital Twin Technology For The Improvement In Depression Among Patients Undergoing Remission Of Diabetes
por: Shashank, Joshi, et al.
Publicado: (2022)

LBSUN294 Insulin-induced Abdominal Acanthosis Nigricans From High Doses Of Insulin U-500
por: Yap, Sara Elizabeth, et al.
Publicado: (2022)

LBSUN154 Baseline Albuminuria May Protect Against Severe Covid-19 In Type 2 Diabetes Patients
por: Bashkin, Amir, et al.
Publicado: (2022)

LBSUN210 Efficacy And Safety Profile Of Insulin Icodec Versus Insulin Glargine U100 In Type 2 Diabetes Mellitus: A Meta-Analysis Of Randomized Controlled Trials
por: Dimayuga, Diana Colleen, et al.
Publicado: (2022)

ODP604 | LBSUN287 Ketosis-prone Type 2 Diabetes (Flatbush Diabetes) In Remission: Report Of Two Cases
por: Ji, Beisi, et al.
Publicado: (2022)

LBSUN180 Preconception Counseling And Reproductive Education Program For People With Diabetes (PREPP'D) - An Educational Program For Underserved Women With Diabetes
por: Wang, Ally W, et al.
Publicado: (2022)

LBSUN215 Evaluation Of Glycemic Control By Continuous Glucose Monitoring Among Hospitalized Older Adults With Type-2 Diabetes And Frailty
por: Idrees, Thaer, et al.
Publicado: (2022)

LBSUN319 Characteristics And Treatment Patterns Of Hispanic/latino Patients Initiating First Injectable Glp-1ra Or Basal Insulin
por: Hoog, Meredith, et al.
Publicado: (2022)

LBSUN206 Provider Prescribing Habits And Use Of Newer Agents For Type 2 Diabetes In A Large Multicenter Health Care System
por: Yaseen, Aseel, et al.
Publicado: (2022)

LBSUN289 Ketonuria — A Possible Early Indicator Of Impending Euglycemic DKA In Setting Of Recent SGLT-2 Inhibitor Use And Acute Stress
por: Arora, Gunjan, et al.
Publicado: (2022)

LBSUN153 Trends In Diabetic Emergencies, A1c Monitoring And Telemedicine Utilization During The Covid Pandemic - A Cross Sectional Study
por: Kennedy, Randol, et al.
Publicado: (2022)

LBSUN320 Building The Evidence To Address Disparities In Type 1 Diabetes (BEAD-T1D): Recruitment Practices To Engage Underrepresented Youth And Their Families
por: Peñaranda, Ricardo Medina, et al.
Publicado: (2022)

LBSUN306 Effects Of Glp-1 Receptor Agonism, Dpp4 Inhibition, And Hypocaloric Diet On Metabolic Parameters In Obese Pre-diabetic Individuals: A Randomized-controlled Trial
por: Mashayekhi, Mona, et al.
Publicado: (2022)

LBSUN162 Cumulative Probability Of Heart Failure Hospitalization Among Non-Hispanic Black Compared To Non-Hispanic White Individuals With Type 2 Diabetes On Empagliflozin (EMPA-AA): Real-world Data
por: Mishriky, Basem M, et al.
Publicado: (2022)

LBSUN290 A Rare, Sordid Tale Of The Two Most Dreaded Adverse Effects Of SGLT-2 Inhibitors Occurring Concurrently - Acute Pancreatitis And Euglycemic Diabetic Ketoacidosis - Within Days Of Initiating Empagliflozin Therapy.
por: Arora, Gunjan, et al.
Publicado: (2022)

LBSUN207 Efficacy And Safety Of Degludec U100 Versus Glargine U300 For The Hospital Management Of Patients With Type 2 Diabetes: A Prospective, Open-label, Non-inferiority Randomized Controlled Trial
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2022)

SUN-677 The Warburg Effect: A Case of Persistent Hypoglycemia and Lactic Acidosis
por: Majety, Priyanka, et al.
Publicado: (2020)

ODP159 A Rare Case of Pembrolizumab Induced Diabetic Ketoacidosis
por: Durrani, Jawahar, et al.
Publicado: (2022)

SAT-676 Pembrolizumab Induced Worsening Glycemic Control and DKA in Type 2 Diabetes Mellitus
por: Goud, Sarita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7ls1kh15iqsnhvvbd91j626f46